Mental Health

IntrusiveThoughts.org takes 'approachable' approach to redesign of OCD site

IntrusiveThoughts.org takes 'approachable' approach to redesign of OCD site

By

Two key creators from Ready Set Rocket share how a thoughtful execution can destigmatize mental illness.

Watch: Psychiatry body kicks off first recruitment campaign with emotive film

Watch: Psychiatry body kicks off first recruitment campaign with emotive film

By

The Royal College of Psychiatrists kicked off a six-week student recruitment campaign with a national media push and an emotive film voiced by patient testimony.

Five things for pharma marketers to know: Friday, August 25, 2017

Five things for pharma marketers to know: Friday, August 25, 2017

By

Google surveys for depression; patients with diabetes that adhere to their regimen had fewer ER visits; Biogen, Samsung scores Humira biosimilar approval in EU

Five things for pharma marketers to know: Tuesday, May 23, 2017

Five things for pharma marketers to know: Tuesday, May 23, 2017

By

Disease awareness ads can boost drug sales; AstraZeneca's experimental asthma drug cuts steroid use; FDA approves Regeneron and Sanofi's RA drug

Study: Medical-marijuana laws lower prescription drug usage

Study: Medical-marijuana laws lower prescription drug usage

The research found a reduction in utilization of medications used to treat depression, nausea, and psychosis when looking at data for Medicaid beneficiaries.

Five things for pharma marketers to know: Tuesday, February 14, 2017

Five things for pharma marketers to know: Tuesday, February 14, 2017

By

More older Americans are taking at least three psychiatric drugs; Marathon to pause launch of Emflaza; Aetna and Humana call off deal

Pfizer creates app for patients with depression

Pfizer creates app for patients with depression

By

The connection to Pristiq is not overt in the app's user interface, though Moodivator is featured on Pristiq's website.

Trump or Clinton? Either May Lead to Better Mental Healthcare

Trump or Clinton? Either May Lead to Better Mental Healthcare

Despite political rifts that have blocked progress on so many other fronts, Congress has managed to lay the groundwork for clear steps forward in mental health.

Five things for pharma marketers to know: Tuesday, October 11, 2016

Five things for pharma marketers to know: Tuesday, October 11, 2016

By

Opdivo fails in lung cancer trial; hedge fund sues Theranos; Takeda and Crescendo partner to develop humabody-based therapies

Five things for pharma marketers to know: Tuesday, October 20, 2015

Five things for pharma marketers to know: Tuesday, October 20, 2015

By

Therapy and low-dose drugs found to aid schizophrenia patients more than just antipsychotics; Clinton calls for investigations into drug price increases; Bayer issues RFP for AOR for consumer care brands

Five things for pharma marketers to know: Tuesday, October 6

Five things for pharma marketers to know: Tuesday, October 6

By

The FDA approves another generic version of Abilify; drug price increases driving profit growth; Spark plans to submit eye-drug to the FDA in 2016